Key highlights
Explore more by category
Showing: 1 – 10 of 66 stories
05 August 2022 – 3 mins read
ILC 2022: Let’s talk PBC
The International Liver Congress (ILC)1 provides a key opportunity for us to meet and discuss the management and research of liver diseases. Given the online format of recent meetings, it was great to have the chance to interact, discuss and…
28 July 2022 – 1 mins read
A message from CEO David Loew
Hear what CEO David Loew has to say about our H1 2022 results.
29 June 2022 – 6 mins read
Ipsen announces U.S. FDA Priority Review for palovarotene New Drug Application in patients with fibrodysplasia ossificans progressiva following resubmission
PARIS, France, 29 June 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its resubmitted New Drug Application (NDA) for investigational palovarotene for the treatment of patients with…
12 May 2022 – 3 mins read
How to transform the medical organization in specialty care to drive best-in-class patient value
By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer
04 March 2022 – 2 mins read
Ukraine situation: What Ipsen is doing
Latest Update: March 29, 2022